search
Back to results

Patient Actor Training to Improve HIV Services for Adolescents in Kenya (SPEED)

Primary Purpose

HIV/AIDS

Status
Completed
Phase
Not Applicable
Locations
Kenya
Study Type
Interventional
Intervention
Clinician training intervention
Sponsored by
University of Washington
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for HIV/AIDS focused on measuring Adolescents, Clinical training, HIV care and treatment, Africa

Eligibility Criteria

10 Years - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Listed by population

Facilities:

  • HIV care and treatment facilities in Kenya with ≥40 adolescents currently in HIV care
  • EMR data systems
  • No concurrent adolescent interventions

Adolescent patient records:

  • Records of adolescents and youth ages 10-24
  • Enrollment in HIV care and treatment at one of the study facilities

Adolescent satisfaction surveys:

  • Patients ages 10-24 seeking counseling or treatment services at trial site who are HIV-infected
  • Willing and able to provide informed consent or assent based on age and presence of a caregiver.
  • Reside in Kenya

Health care workers:

  • >18 years of age
  • Employed at trial site in clinical care for at least three months and/or have a 1 year contract (i.e. not temporary staff)
  • Provide clinical services to adolescents
  • Reside in Kenya

Exclusion Criteria:

Facilities:

  • If inclusion criteria are not met
  • If anything would prevent the complete conduct of the training intervention at that site and/or the collection of outcome measures

Adolescents and health care worker surveys:

• If an individual has conditions that would place them at increased risk or preclude the individual's full compliance with or completion of the study

Sites / Locations

  • HIV care facility 6
  • HIV care facility 3
  • HIV care facility 4
  • HIV care facility 5
  • HIV care facility 1
  • HIV care facility 2

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention period

Control period

Arm Description

In this stepped-wedge trial design, the experimental arm refers to the time period when the study sites receive the clinician training intervention. The intervention is a clinician training using standardized patient actors to improve communication and empathy skills of health care providers who serve HIV-positive adolescents and youth.

In this stepped-wedge trial design, the no intervention arm refers to the time period before the study sites receive the clinician training intervention, during which standard of care is provided.

Outcomes

Primary Outcome Measures

Retention in HIV care
The primary outcome is change in retention in HIV care between the intervention and control periods, where retention is defined as return for first follow-up visit within 3 months among newly enrolled adolescent clients OR follow-up visit after 're-engagement visit' (after lost-to-follow-up for >90 days since last visit, with no record of death or transfer).

Secondary Outcome Measures

Proportion of HCWs with pass/fail scores
The proportion of HCW participants who achieved competency upon completion of the training.
Numeric scores from SP actors
All SP actors will complete a check-list to provide non-technical feedback to each HCW participant. Scores will be used to compute the overall pass/fail score at completion of the training.
Health care worker competency
This outcome is measured as change in mean competency score between intervention and control periods using a structured survey.
Health care workers' satisfaction with skills
This outcome is measured as change in mean satisfaction scores between intervention (post-training) and control periods (pre-training), using a structured survey. These surveys will be conducted at baseline, and every nine months at the end of the training in each wave. Exit interviews among trained participants will be conducted about one year after each training wave for up to four waves to complement the quantitative results.
Adolescent patients' satisfaction with care
This outcome is defined as mean change in satisfaction score between intervention and control periods, using a structured survey.
Cost per additional HIV-infected adolescent retained in care
This outcome measure will be computed based on a mathematical model of total direct and indirect costs using a combination of primary data collection (surveys), program data, and published literature. The denominator will be the number of adolescents retained in care.
Cost-utility of the intervention
This outcome measure will be computed using a mathematical model of cost per life year saved and disability-adjusted life year (DALY), where cost data will come from primary data, program records, and literature, and denominator data will come from the most relevant models of DALYs for adolescents.
Retention in HIV care (secondary)
A secondary measure of retention in HIV care is return for any follow-up visit within 3 months (90 days) among currently enrolled HIV-positive adolescent patients

Full Information

First Posted
September 26, 2016
Last Updated
June 8, 2021
Sponsor
University of Washington
Collaborators
University of Nairobi
search

1. Study Identification

Unique Protocol Identification Number
NCT02928900
Brief Title
Patient Actor Training to Improve HIV Services for Adolescents in Kenya
Acronym
SPEED
Official Title
Simulated Patient Encounters to Promote Early Detection and Engagement in HIV Care for Adolescents
Study Type
Interventional

2. Study Status

Record Verification Date
June 2021
Overall Recruitment Status
Completed
Study Start Date
September 26, 2016 (Actual)
Primary Completion Date
November 2, 2020 (Actual)
Study Completion Date
March 31, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Washington
Collaborators
University of Nairobi

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The goal of this study is to develop and evaluate a clinical training intervention utilizing standardized patient actors to improve communication and interpersonal skills of health care workers who serve HIV-infected adolescents and youth in Kenya, resulting in increased engagement in HIV care. The effect of the intervention on retention in care will be evaluated in a stepped-wedge randomized controlled trial at 24 HIV care and treatment facilities.
Detailed Description
Adolescents and youth have the highest HIV incidence rates compared to any other age strata. Inadequate provision of accessible and acceptable HIV testing, counseling, and treatment services has been cited as a barrier to uptake of and retention in HIV care in this population. The "SPEED" study aims to develop and evaluate a clinical training intervention utilizing Standardized Patient (SP) actors to improve communication and interpersonal skills of health care workers (HCWs) who work with adolescents and youth (ages 10-24), resulting in increased engagement in HIV care in Kenya. This intervention includes a series of role plays between HCW participants and professional Kenyan actors, followed by feedback and debriefing sessions. The hypothesis is that SP encounters will increase HCW confidence and capacity to facilitate HIV status disclosure and provide supportive interactions with HIV-infected youth, which will in turn increase uptake and improve retention in HIV services among adolescents and youth. The pilot phase (Aim 1) will consist of developing patient case scripts specific to adolescent HIV-related care and counseling needs and establishing HCW competency scores. To evaluate the intervention, a cluster randomized controlled stepped-wedge trial will be conducted in 24 HIV care and treatment facilities to assess the impact of SP encounters on the proportion of adolescents and youth patients retained in care at HIV treatment facilities in Kenya (Aim 2). Finally, the cost effectiveness and cost utility of the SP intervention will be determined (Aim 3). The estimated study duration is five years. The primary outcomes from Aim 1 are final scripts and pass/fail scores for use in SP encounters. The primary outcome for the randomized controlled trial (RCT) (Aim 2) is retention in care among HIV-positive adolescents and youth, based on electronic medical records data. Secondary outcomes will include satisfaction (patients and HCWs), HCW competency in youth- friendly counseling, antiretroviral therapy adherence, and viral suppression. For the cost effectiveness and cost utility analyses (Aim 3), the cost per additional HIV-infected adolescent/youth retained in care and the cost per additional life year saved and disability-adjusted life averted will be estimated.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV/AIDS
Keywords
Adolescents, Clinical training, HIV care and treatment, Africa

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
7450 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention period
Arm Type
Experimental
Arm Description
In this stepped-wedge trial design, the experimental arm refers to the time period when the study sites receive the clinician training intervention. The intervention is a clinician training using standardized patient actors to improve communication and empathy skills of health care providers who serve HIV-positive adolescents and youth.
Arm Title
Control period
Arm Type
No Intervention
Arm Description
In this stepped-wedge trial design, the no intervention arm refers to the time period before the study sites receive the clinician training intervention, during which standard of care is provided.
Intervention Type
Behavioral
Intervention Name(s)
Clinician training intervention
Intervention Description
This intervention is a clinician training using SP actors to improve communication and empathy skills of HIV care providers who serve HIV-positive adolescents and youth in Kenya.
Primary Outcome Measure Information:
Title
Retention in HIV care
Description
The primary outcome is change in retention in HIV care between the intervention and control periods, where retention is defined as return for first follow-up visit within 3 months among newly enrolled adolescent clients OR follow-up visit after 're-engagement visit' (after lost-to-follow-up for >90 days since last visit, with no record of death or transfer).
Time Frame
Up to four years after baseline
Secondary Outcome Measure Information:
Title
Proportion of HCWs with pass/fail scores
Description
The proportion of HCW participants who achieved competency upon completion of the training.
Time Frame
Up to one month after last day of training
Title
Numeric scores from SP actors
Description
All SP actors will complete a check-list to provide non-technical feedback to each HCW participant. Scores will be used to compute the overall pass/fail score at completion of the training.
Time Frame
Up to one week after last day of training
Title
Health care worker competency
Description
This outcome is measured as change in mean competency score between intervention and control periods using a structured survey.
Time Frame
Baseline and every nine months for up to four years
Title
Health care workers' satisfaction with skills
Description
This outcome is measured as change in mean satisfaction scores between intervention (post-training) and control periods (pre-training), using a structured survey. These surveys will be conducted at baseline, and every nine months at the end of the training in each wave. Exit interviews among trained participants will be conducted about one year after each training wave for up to four waves to complement the quantitative results.
Time Frame
Baseline and every nine months for up to four years
Title
Adolescent patients' satisfaction with care
Description
This outcome is defined as mean change in satisfaction score between intervention and control periods, using a structured survey.
Time Frame
Baseline and every nine months for up to four years
Title
Cost per additional HIV-infected adolescent retained in care
Description
This outcome measure will be computed based on a mathematical model of total direct and indirect costs using a combination of primary data collection (surveys), program data, and published literature. The denominator will be the number of adolescents retained in care.
Time Frame
End of study, up to four years
Title
Cost-utility of the intervention
Description
This outcome measure will be computed using a mathematical model of cost per life year saved and disability-adjusted life year (DALY), where cost data will come from primary data, program records, and literature, and denominator data will come from the most relevant models of DALYs for adolescents.
Time Frame
End of study, up to four years
Title
Retention in HIV care (secondary)
Description
A secondary measure of retention in HIV care is return for any follow-up visit within 3 months (90 days) among currently enrolled HIV-positive adolescent patients
Time Frame
Baseline and every nine months for up to four years
Other Pre-specified Outcome Measures:
Title
antiretroviral (ART) adherence in HIV-positive adolescents
Description
This measure is defined as change in the proportion of visits with ART refills within 1 week of scheduled visit between intervention and control periods using available electronic medical record (EMR) data.
Time Frame
Baseline and every nine months for up to four years
Title
Viral load in HIV-positive adolescents
Description
This measure is defined as change in viral load between intervention and control periods using available EMR data.
Time Frame
Baseline and every nine months for up to four years
Title
Linkage to adolescent friendly services in HIV-positive adolescents
Description
This measure is defined as change in the proportion of visits with referrals to affiliated services (e.g. family planning) between intervention and control periods using available EMR data.
Time Frame
Baseline and every nine months for up to four years
Title
AIDS defining illness in HIV-positive adolescents
Description
This measure is defined as change in the proportion of visits with any AIDS defining illness between intervention and control periods using available EMR data.
Time Frame
Baseline and every nine months for up to four years
Title
Mortality in HIV-positive adolescents
Description
This measure is defined as change in the proportion of deaths between intervention and control periods using available EMR data.
Time Frame
Baseline and every nine months for up to four years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Listed by population Facilities: HIV care and treatment facilities in Kenya with ≥40 adolescents currently in HIV care EMR data systems No concurrent adolescent interventions Adolescent patient records: Records of adolescents and youth ages 10-24 Enrollment in HIV care and treatment at one of the study facilities Adolescent satisfaction surveys: Patients ages 10-24 seeking counseling or treatment services at trial site who are HIV-infected Willing and able to provide informed consent or assent based on age and presence of a caregiver. Reside in Kenya Health care workers: >18 years of age Employed at trial site in clinical care for at least three months and/or have a 1 year contract (i.e. not temporary staff) Provide clinical services to adolescents Reside in Kenya Exclusion Criteria: Facilities: If inclusion criteria are not met If anything would prevent the complete conduct of the training intervention at that site and/or the collection of outcome measures Adolescents and health care worker surveys: • If an individual has conditions that would place them at increased risk or preclude the individual's full compliance with or completion of the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pamela Kohler, PhD, MPH, RN
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Dalton Wamalwa, MMed, MPH
Organizational Affiliation
University of Nairobi
Official's Role
Study Director
Facility Information:
Facility Name
HIV care facility 6
City
Homa Bay
Country
Kenya
Facility Name
HIV care facility 3
City
Kiambu
Country
Kenya
Facility Name
HIV care facility 4
City
Kiambu
Country
Kenya
Facility Name
HIV care facility 5
City
Kisumu
Country
Kenya
Facility Name
HIV care facility 1
City
Nairobi
Country
Kenya
Facility Name
HIV care facility 2
City
Nairobi
Country
Kenya

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The study investigators are prepared to share data with other researchers in accordance with NIH policies and other local regulations.
Citations:
PubMed Identifier
34939987
Citation
Wilson K, Onyango A, Mugo C, Guthrie B, Slyker J, Richardson B, John-Stewart G, Inwani I, Bukusi D, Wamalwa D, Kohler P. Kenyan HIV Clinics With Youth-Friendly Services and Trained Providers Have a Higher Prevalence of Viral Suppression Among Adolescents and Young Adults: Results From an Observational Study. J Assoc Nurses AIDS Care. 2022 Jan-Feb 01;33(1):45-53. doi: 10.1097/JNC.0000000000000302.
Results Reference
derived
PubMed Identifier
29282109
Citation
Wilson KS, Mugo C, Bukusi D, Inwani I, Wagner AD, Moraa H, Owens T, Babigumira JB, Richardson BA, John-Stewart GC, Slyker JA, Wamalwa DC, Kohler PK. Simulated patient encounters to improve adolescent retention in HIV care in Kenya: study protocol of a stepped-wedge randomized controlled trial. Trials. 2017 Dec 28;18(1):619. doi: 10.1186/s13063-017-2266-z.
Results Reference
derived

Learn more about this trial

Patient Actor Training to Improve HIV Services for Adolescents in Kenya

We'll reach out to this number within 24 hrs